RankingsLogo

Incyte Corporation

Incyte Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Incyte Corporation is an American multinational pharmaceutical company. The company operates manufacturing, research and development into biopharmaceutical medical solutions in areas like autoimmunity, inflammation and oncology.

Ticker: INCY

Humankind Value: $18.1 B

Revenue: $2.9 B

Market Cap: $16.6 B

Badge100_2023
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Incyte Corporation has a net positive value on humanity, primarily due to Healthcare R&D ($15.6 B), Pharmaceuticals ($2.0 B), and Economic Value ($722.4 M). Positive value from Healthcare R&D and Pharmaceuticals is linked to an estimate of 340,000 additional years lived by people worldwide. Incyte Corporation can increase its Humankind Value by addressing impacts related to Biofuel Production (-$397.5 M) and Greenhouse Gases (-$118.1 M). Healthcare R&D, Pharmaceuticals, Economic Value, and Greenhouse Gases are attached to Incyte Corporation as a result of its direct business activities. Biofuel Production is mostly or entirely a result of supply-chain relationships.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings